Inventurus Knowledge Solutions Ltd
IKS NSE
Inventurus Knowledge Solutions Ltd
Information TechnologyNSE: IKS BSE: 544309 IT Enabled Services
Key Fundamentals
SmallcapIT Enabled ServicesInformation TechnologyMarket Cap
₹31,424 Cr
Volatility
Moderate
P/E Ratio
41.69
EBITDA
₹1,082 Cr
Return on Equity
27.16%
Debt to Equity
0.48
Book Value
₹163.13
52W High
₹1,933
52W Low
₹1,262
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Inventurus Knowledge Solutions Ltd insights
38 extracted metrics + investor summaries across FY16–FY27.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company has delivered good profit growth of 34.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 37.0%
Weaknesses
2- Stock is trading at 14.0 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
Growth Rate
Revenue Growth
18.16% ↗
Net Income Growth
44.94% ↗
Cash Flow Change
51.54% ↗
ROE
-15.13% ↘
ROCE
22.60% ↗
EBITDA Margin (Avg.)
12.63% ↗
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 2d agoAI opinion · based on fundamentals
Risk high
Inventurus Knowledge Solutions (IKS) is a Rs 31,141 crore IT services company trading at a PE of 40.1x with strong historical growth metrics—5-year profit CAGR of 34.2% and 3-year ROE of 37%—but commands a premium valuation at 10.94x book value with zero dividend payout.
Bull Case 7
- Strong profit growth with 5-year compounded profit CAGR of 34% and TTM profit growth accelerating to 41%
- Consistently high return on equity at 40% last year, 37% over 3 years, and 39% over 5 years, indicating efficient capital allocation
- Robust revenue growth with 5-year compounded sales CAGR of 42% and 3-year CAGR of 46%, demonstrating sustained demand
- TTM sales growth of 21% shows continued momentum even on a larger revenue base
- Stock has delivered 18% returns over 1 year, reflecting positive market sentiment
- Profit growth (41% TTM) significantly outpacing revenue growth (21% TTM) suggests expanding margins and operating leverage
- Market cap of Rs 31,141 crore provides reasonable scale and liquidity for an IT services firm
Bear Case 8
- Stock trades at 14.1x book value, a steep premium that leaves limited margin of safety if growth decelerates
- PE ratio of 40.1x is elevated relative to broader IT sector averages, pricing in significant future growth
- Zero dividend yield despite repeated profitability indicates no shareholder returns via payouts
- Limited trading history with no meaningful 3-year, 5-year, or 10-year stock CAGR data available, making long-term track record assessment difficult
- 52-week high and low data unavailable (showing 0), making it difficult to assess current price relative to recent trading range
- Debt-to-equity ratio not disclosed, creating uncertainty about balance sheet leverage
- Revenue growth has decelerated from 46% (3-year CAGR) to 21% (TTM), signaling potential growth normalization
- No 10-year financial history available, limiting ability to assess performance through full economic cycles
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 17h ago Positives 4
- Strong Q1 profit up 28% YoY Aug 5
Consolidated net profit rose 28% YoY to ₹1,937.41M in Q1FY27. Revenue grew 21% to ₹8,936.29M and EBITDA margin expanded to 33.01% from 32.12%.
- Abridge AI stake sold for $10M Aug 6
US subsidiary sold Series A-1 Preferred Shares in Abridge AI Inc for USD 10,000,175 to Alpha Square Group Fund IV, LP under agreement dated Aug 5, 2026.
- US ACO subsidiary incorporated Jul 29
Incorporated Value Partners Collective ACO, LLC in the US to pursue CMS's LEAD program for value-based healthcare management.
- TruBridge deal financing syndicated Aug 3
Executed syndication agreement for TruBridge acquisition with Citigroup, Deutsche Bank, and JPMorgan as arrangers, with multiple new lenders joining the facility.
Neutral 3
- Analyst meets scheduled Aug 14-18 Aug 11
Hosting one-on-one meet with six institutional investors on Aug 14 and participating in Motilal Oswal 22nd Annual Global Investor Conference on Aug 18 in Mumbai.
- Shareholders approve subsidiary pledge Aug 7
Two special resolutions passed via postal ballot approving pledge/disposal of material subsidiary shares and creation of additional security for US subsidiary.
- Q1FY27 earnings call held Aug 6 Aug 6
Audio recording of Q1 FY2026-27 earnings conference call held on Aug 6 at 8:30 AM IST released under SEBI LODR regulations.
TL;DR: IKS delivered a strong Q1FY27 with 28% profit growth, 21% revenue growth, and margin expansion to 33%. The company is actively expanding in the US via a new ACO subsidiary and the TruBridge acquisition syndication. No material headwinds emerged this period. The forward outlook is constructive given operational momentum, strategic US healthcare bets, and investor engagement activity.
Quarterly Results
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 567 | 620 | 640 | 643 | 657 | 724 | 740 | 781 | 815 | 858 | 894 |
| Expenses | 405 | 494 | 467 | 454 | 476 | 498 | 502 | 511 | 536 | 563 | 604 |
| Operating Profit | 162 | 126 | 173 | 189 | 181 | 226 | 238 | 270 | 279 | 295 | 290 |
| OPM % | 29% | 20% | 27% | 29% | 28% | 31% | 32% | 35% | 34% | 34% | 32% |
| Other Income | 6 | 15 | 4 | 5 | 27 | 3 | 3 | 4 | 6 | 5 | 6 |
| Interest | 26 | 32 | 26 | 22 | 21 | 21 | 18 | 16 | 23 | 13 | 10 |
| Depreciation | 19 | 27 | 28 | 28 | 28 | 28 | 28 | 30 | 32 | 34 | 34 |
| PBT | 124 | 81 | 122 | 144 | 160 | 180 | 195 | 228 | 229 | 253 | 251 |
| Tax % | 18% | 21% | 22% | 21% | 19% | 18% | 22% | 21% | 20% | 19% | 23% |
| Net Profit | 102 | 64 | 95 | 113 | 130 | 148 | 152 | 181 | 183 | 206 | 194 |
| EPS in Rs | 5.94 | 3.72 | 5.57 | 6.59 | 7.56 | 8.61 | 8.83 | 10.53 | 10.68 | 12 | 11.29 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 529 | 553 | 764 | 1,031 | 1,818 | 2,664 | 3,194 | 3,347 |
| Expenses | 367 | 348 | 466 | 639 | 1,297 | 1,893 | 2,112 | 2,213 |
| Operating Profit | 162 | 205 | 298 | 392 | 521 | 771 | 1,082 | 1,134 |
| OPM % | 31% | 37% | 39% | 38% | 29% | 29% | 34% | 34% |
| Other Income | 31 | 16 | 1 | -2 | 40 | 39 | 17 | 20 |
| Interest | 7 | 8 | 7 | 6 | 61 | 91 | 70 | 62 |
| Depreciation | 40 | 30 | 23 | 25 | 59 | 113 | 124 | 131 |
| PBT | 145 | 183 | 269 | 359 | 442 | 606 | 905 | 961 |
| Tax % | 5% | 9% | 13% | 15% | 16% | 20% | 20% | — |
| Net Profit | 137 | 165 | 233 | 305 | 370 | 486 | 722 | 764 |
| EPS in Rs | 167 | 200 | 13.61 | 17.86 | 21.68 | 28.33 | 42.03 | 44.5 |
| Div. Payout % | 0% | 12% | 393% | 55% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 275 | 449 | 630 | 812 | 1,141 | 1,773 | 2,224 |
| Borrowings | 0 | 76 | 65 | 52 | 1,311 | 856 | 766 |
| Other Liabilities | 151 | 53 | 75 | 107 | 411 | 274 | 600 |
| Total Liabilities | 434 | 586 | 788 | 988 | 2,880 | 2,919 | 3,606 |
| Fixed Assets | 36 | 87 | 76 | 59 | 1,833 | 1,790 | 1,863 |
| CWIP | 0 | 0 | 0 | 0 | 3 | 13 | 2 |
| Investments | 1 | 14 | 16 | 32 | 195 | 114 | 361 |
| Other Assets | 397 | 485 | 695 | 898 | 849 | 1,003 | 1,380 |
| Total Assets | 434 | 586 | 788 | 988 | 2,880 | 2,919 | 3,606 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | 163 | 175 | 233 | 288 | 210 | 318 | 674 |
| Investing | -79 | -167 | -82 | -158 | -1,137 | 241 | -210 |
| Financing | -41 | -37 | -59 | -152 | 780 | -389 | -412 |
| Net Cash Flow | 43 | -28 | 92 | -22 | -147 | 170 | 52 |
| Free Cash Flow | 152 | 168 | 222 | 280 | 177 | 276 | 613 |
| CFO/OP | 118 | 100 | 93 | 93 | 58 | 56 | 80 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 51 | 49 | 46 | 57 | 73 | 73 | — |
| Cash Conversion Cycle | 51 | 49 | 46 | 57 | 73 | 73 | — |
| Working Capital Days | 20 | 41 | 15 | 21 | -75 | 10 | — |
| ROCE % | — | 47% | 47% | 50% | 30% | 27% | — |
Documents
1
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - Q4 FY2025-26 earnings conference call scheduled for May 14, 2026 at 8:30 AM IST. 2d - Q4 FY2025-26 earnings conference call scheduled for May 14, 2026 at 8:30 AM IST.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 Apr - Newspaper Advertisement confirming dispatch of Postal Ballot Notice. 29 Apr - Newspaper Advertisement confirming dispatch of Postal Ballot Notice.
4
Announcement Under Regulation 30 (LODR)-Conference Call Transcript
29 Apr - Transcript of Conference Call held on April 24, 2026. 29 Apr - Transcript of Conference Call held on April 24, 2026.
5
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
5 May - Board meets May 13, 2026 to approve audited Q4 and FY26 financial results; trading window closed till May 15. 5 May - Board meets May 13, 2026 to approve audited Q4 and FY26 financial results; trading window closed till May 15.
Frequently Asked Questions about Inventurus Knowledge Solutions Ltd
What does Inventurus Knowledge Solutions Ltd do?
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]
Where is Inventurus Knowledge Solutions Ltd (IKS) listed?
Inventurus Knowledge Solutions Ltd is listed on the Indian stock exchanges. It is listed on NSE: IKS and BSE: 544309. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Inventurus Knowledge Solutions Ltd belong to?
Inventurus Knowledge Solutions Ltd operates in the Information Technology sector within the IT Enabled Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd has a market capitalisation of approximately ₹31423.62 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Inventurus Knowledge Solutions Ltd?
The Price-to-Earnings (PE) ratio of Inventurus Knowledge Solutions Ltd is 41.69. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Inventurus Knowledge Solutions Ltd?
Over the past 52 weeks, Inventurus Knowledge Solutions Ltd has traded between a low of ₹1,262 and a high of ₹1,933. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd has a Return on Equity (ROE) of 27.16%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Inventurus Knowledge Solutions Ltd on Tapetide?
On Tapetide, you can view Inventurus Knowledge Solutions Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]
Website ikshealth.com
CEO Mr. Sachin K. Gupta
Employees 7,530
Listed 2024-12-19
Face Value ₹ 1
Issued Size 17,15,73,159